Is neuropathic pain an overlooked symptom in axial spondyloarthritis?
Abstract
Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatologic disease. Pain is the most common symptom affecting quality of life in axSpA patients. It has been showed that pain is not always correlated with inflammation in patients. The aim of our study was to investigate the frequency of neuropathic pain in axSpA patients and relationship between neuropathic pain and patient characteristics.
Materials and Methods: Patients diagnosed as axSpA according to the Assessment of SpondyloArthritis International Society classification criteria, who presented in our outpatients clinics from January to March 2019 were included in this study. The neuropathic component of pain was evaluated with Douleur Neuropathique en 4 Questions (DN4) questionnaire.
Results: Eighty seven axSpA patients were included in the study. Thirty of patients had neuropathic pain according to DN4 questionnaire (DN4>4). Neuropathic pain was higher in active disease group depending on both of ASDAS-CRP and BASDAI. DN4 score of patients was found moderately correlated with ASDAS-CRP and BASDAI score. A weak positive correlation was found between patients education level and DN4 score.
Conclusion: We showed that neuropathic pain could be seen in patients with axSpA and it could be correlated with disease activity. The studies have proven that neuropathic pain could lead to impaired quality of life and social & emotional functions. Patients with neuropathic pain could not benefit from antiinflammatory treatments. Therefore evaluating of neuropathic pain is important in axSpA patients. Further studies on management of neuropathic pain in axSpA patients are needed.
Keywords
neuropathic pain , inflammatory pain , disease activity , spondyloarthritis
Kaynakça
- 1. McDougall JJ. Arthritis and pain. Neurogenic origin of joint pain. Arthritis research & therapy. 2006;8(6):1-10.
- 2. Rifbjerg-Madsen S, Christensen A, Christensen R, Hetland ML, Bliddal H, Kristensen L, et al. Pain and pain mechanisms in patients with inflammatory arthritis: a Danish nationwide cross-sectional DANBIO registry survey. PLoS One. 2017;12(7):e0180014.
- 3. Kim T, Son S, Lee J. Neuropathic pain in ankylosing spondylitis: a meta-analysis. Zeitschrift für Rheumatologie. 2020;79(1):95-102.
- 4. Wu Q, Inman RD, Davis KD. Neuropathic pain in ankylosing spondylitis: a psychophysics and brain imaging study. Arthritis & Rheumatism. 2013;65(6):1494-503.
- 5. Gok K, Cengiz G, Erol K, Ozgocmen S. Neuropathic pain component in axial spondyloarthritis and the influence on disease burden. JCR: Journal of Clinical Rheumatology. 2018;24(6):324-7.
- 6. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). pain. 2005;114(1-2):29-36.
- 7. Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. The Journal of Pain. 2010;11(11):1129-35.
- 8. Lee Y, Song G. Janus kinase inhibitors for treating active ankylosing spondylitis: a meta-analysis of randomized controlled trials. Zeitschrift für Rheumatologie. 2020:1-6.
- 9. Gauffin J, Hankama T, Kautiainen H, Hannonen P, Haanpää M. Neuropathic pain and use of PainDETECT in patients with fibromyalgia: a cohort study. BMC neurology. 2013;13(1):1-6.
- 10. Zhou L, Li T, Wu X, Lu H, Lin L, Ye L, et al. Assessment of Neuropathic Pain in Ankylosing Spondylitis: Prevalence and Characteristics. Pain and Therapy. 2021;10(2):1467-79.
